News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Catalent Pharma Solutions and Aegerion Pharmaceuticals, Inc. (AEGR) Partner on Launch of Newly FDA Approved JUXTAPID™


1/8/2013 9:22:58 AM

SOMERSET, N.J.--(BUSINESS WIRE)--After a close 7-year partnership on clinical development, Catalent and Aegerion will partner for international supply for newly FDA approved JUXTAPID™ (lomitapide) capsules as an adjunct to a low-fat diet and other lipid-lowering treatments in patients with homozygous familial hypercholesterolemia (HoFH).

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES